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Abstract
Background: Meleagrid herpesvirus 1 (MeHV-1) infectious bacterial artificial chromosomes (iBACs) are ideal vectors
for the development of recombinant vaccines for the poultry industry. However, the full potential of iBACS as
vectors can only be realised after thorough genetic characterisation, including identification of those genetic
locations that are non-essential for virus replication. Generally, transposition has proven to be a highly effective
strategy for rapid and efficient mutagenesis of iBAC clones. The current study describes the characterisation of 34
MeHV-1 mutants containing transposon insertions within the pMeHV1-C18 iBAC genome.
Methods: Tn5 and MuA transposition methods were used to generate a library of 76 MeHV-1 insertion mutants.
The capacity of each mutant to facilitate the recovery of infectious MeHV-1 was determined by the transfection of
clone DNA into chicken embryo fibroblasts.
Results: Attempts to recover infectious virus from the modified clones identified 14 genetic locations that were
essential for MeHV-1 replication in cell culture. Infectious MeHV-1 was recovered from the remaining 14 intragenic
insertion mutants and six intergenic insertion mutants, suggesting that the respective insertion locations are
non-essential for MeHV-1 replication in cell culture.
Conclusions: The essential and non-essential designations for those MeHV-1 genes characterised in this study were
generally in agreement with previous reports for other herpesviruses homologues. However, the requirement for
the mardivirus-specific genes LORF4A and LORF5 are reported for the first time. These findings will help direct future
work on the development of recombinant poultry vaccines using MeHV-1 as a vector by identifying potential
transgene insertion sites within the viral genome.
Background
Meleagrid herpesvirus 1 (MeHV-1), commonly known as
turkey herpesvirus (HVT), is a non-pathogenic avian
herpesvirus originally isolated from turkeys in 1969 [1, 2].
The virus is assigned to the genus Mardivirus, which also
includes oncogenic Gallid herpesvirus 2 (GaHV-2), the
causative agent of Marek’s disease (MD), and the non-
oncogenic Gallid herpesvirus 3 (GaHV-3). Marek’s disease
is a highly contagious neoplastic poultry disease of major
economic significance worldwide. The close antigenic
relationship amongst the mardiviruses has been exploited
since the 1970s through the use of MeHV-1 as a live
vaccine to reduce production losses resulting from MD
[3]. However, despite widespread vaccination with either
MeHV-1, bivalent vaccines containing MeHV-1/GaHV-3
or attenuated GaHV-2 strains, MD outbreaks continue to
occur. The isolation of GaHV-2 field strains of increased
virulence has been correlated with the loss of protective
capacity of these vaccines, which reinforces the need for
development of improved MD vaccines [4, 5]. It is likely
that novel vaccines targeting GaHV-2 will be constructed
using recombinant DNA technologies, for which MeHV-1
is ideally suited as a vector candidate.
In addition to its use as a vaccine against MD, MeHV-
1 is also widely utilised as a recombinant vaccine vector
for poultry diseases such as infectious laryngotracheitis,
Newcastle disease, infectious bursal disease and highly
pathogenic avian influenza [6–9]. Currently, only a
limited number of transgene insertion sites are used in
the development of recombinant MeHV-1 based
vaccines. Use of a suboptimal insertion site can have a
pronounced effect on vaccine efficacy. For example, Gao
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et al. [10] reported a reduced post-challenge mortality with
highly pathogenic avian influenza virus when the haem-
agglutinin gene was expressed from the MeHV-1 US2 locus
compared to the US10 locus, likely because in vivo virus
replication was more affected with the disruption of US10
compared to US2. Thus the identification of alternative
transgene insertion sites will be useful for the optimisation
of MeHV-1 as a vaccine vector.
The MeHV-1 genome is 159,160 bp in length and has a
type 4 herpesvirus genomic structure [11, 12]. It comprises
a unique long (UL) and a unique short (US) region, flanked
by terminal/internal repeat long (TRL/IRL) and short
segments (TRS/IRS), respectively [11, 12]. In addition, the
genomic termini comprise telomeric repeats, or a-like
sequences, of variable length, which are cis-acting elements
involved in genome packaging [13]. These a-like sequences
are also present at the IRL/IRS junction [11]. For compara-
tive purposes, this article refers to individual genes by their
putative human herpesvirus 1 (HHV-1) homologue, using
UL and US nomenclature [14]. Genes unique to mardi-
viruses are identified by their protein designation, as
described in the MeHV-1 reference sequence [Genbank:
NC_002641.1] [11]. The complete MeHV-1 genome
encodes 79 putative genes [12]. Of these, 73 are single copy;
66 within the UL region and seven in the US region. The
genes vNR13 and icp4 are duplicated, with one copy of each
located in the IRS and TRS elements. The US8 gene, encod-
ing the envelope glycoprotein E (gE), spans the TRS-US
boundary region; consequently, the gene US8*, located
within the IRS, is a truncated duplication of US8. Current
knowledge of MeHV-1 gene function has largely been
extrapolated from studies on GaHV-2, and more broadly
from genetic studies of HHV-1 and other herpesviruses.
While MeHV-1 is currently utilised as a vaccine vector, a
more detailed understanding of the genetic background of
this virus is required to facilitate its further development as
a vector.
The establishment of infectious bacterial artificial
chromosome (iBAC) technologies for herpesvirus muta-
genesis has simplified the process of generating modified
viruses for functional studies and recombinant vaccine
construction. For global genome mutagenesis studies,
transposition has previously been proven to be a valuable
tool, since the random insertion of transposon sequences
allows for the efficient generation of a library of unique
insertional mutants. These mutants can then be screened
to determine if the transposon insertion affects the repli-
cation capacity of the virus in cell culture [15–19]. In this
way, non-essential genetic loci can be readily identified,
and concurrently tested for their potential to carry trans-
genes for the subsequent generation of recombinant
vaccines.
The aim of this study was to characterise a MeHV-1
iBAC transposition library by determining the site of
transposon insertion and the impact on viral replication in
cell culture. Overall, twenty non-essential loci were identi-
fied within the MeHV-1 genome. Additionally, the require-
ment for the mardivirus-specific genes LORF4A and
LORF5 are reported for the first time.
Results
Transposition into a MeHV-1 BAC
The MeHV-1 iBAC clone used in this study was pMeHV1-
C18. It has recently been reported that pMeHV1-C18 has
an in vitro replication capacity similar to wild-type MeHV-
1 despite lacking functional copies of seven genes [20]. The
construction of a combined Tn5 and MuA transposition
library of pMeHV1-C18 has been described previously [21].
Two transposition systems, Tn5 and MuA, were utilised
during the generation of this library due to the early finding
that the MeHV-1 genome is partially resistant to Tn5 trans-
position. The MuA transposon construct was engineered to
contain an eGFP marker gene. Due to the observed resist-
ance to Tn5 transposition, only a minimal Tn5 transposon
construct was successfully utilised for Tn5 transposition.
Briefly, the final library contained 76 mutants with inser-
tions mapping to the MeHV-1 genome, disrupting 30 intra-
genic and six intergenic locations (Table 1; Additional file 1:
Supplemental Table S1). Constructs were screened by
restriction enzyme analysis and by bi-directional Sanger
sequencing outwards from the 5’ and 3’ termini of the
transposon insertion [21]. Results from these screening
analyses were consistent with a single insertion event
occurring within each construct.
Forty-seven insertion events mapped to within the UL
genomic region, three events mapped to the US region, two
insertions were identified within the IRL/TRL regions and
22 insertions mapped to the IRS/TRS regions. Additionally,
two insertions mapped to the a-like sequences. Recovery of
virus from transposed clones was assessed by observing
characteristic MeHV-1 cytopathic effect (CPE) using light
microscopy, and whenever possible, by detecting the
expression of enhanced green fluorescent protein (eGFP)
using fluorescent microscopy (the MuA transposon used to
generate MuAΔ48-84 contained an eGFP transgene)
(Fig. 1). Cell monolayers were passaged at least once after
CPE was evident to confirm the presence of infectious
virus. Where CPE was not observed, monolayers were blind
passaged three to four times to confirm the absence of in-
fectious virus.
Transposition into the UL region
Within the UL genomic region, 25 genes were disrupted by
transposon insertion events. Of these, 13 and 12 locations
were found to be essential and non-essential for replication
of MeHV-1 in cell culture respectively (Table 1).
Although UL13 and UL53 transposition mutants were
classed as non-essential based on the observation of
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persistent eGFP expression after multiple passages, the
recovered viruses from these clones showed severely
attenuated replication in cell culture compared to the
parental virus (Fig.1e and 1f, Table 1).
The UL21 disruption mutants, Tn5Δ14, MuAΔ37 and
MuAΔ41, also caused a very low grade CPE compared to
the parental virus. As these constructs were generated
with transposons lacking the eGFP reporter gene, expres-
sion of eGFP could not be used to verify virus replication
in these clones. Instead, these clones were confirmed to
facilitate the recovery of infectious MeHV-1 through
detection of viral DNA in the cell monolayer using PCR
after three or more passages. To exclude the possibility
that the PCR assay was amplifying residual transfected
iBAC DNA, the pMeHV1-C18-MuAΔ64 construct, a
non-infectious glycoprotein B disruption mutant (Fig. 1g
and 1h), was assayed in parallel with the same PCR assay.
As expected, no pMeHV1-C18-MuAΔ64 DNA was
detectable at passage three, confirming that DNA detected
from UL21 disruption mutants was due to ongoing viral
replication. Based on the continued detection of viral
DNA, the UL21 insertion site was designated as non-
essential for MeHV-1 replication in cell culture, although
replication was markedly impaired.
Table 1 Summary of transposon-mediated gene interruptions within the coding regions of the MeHV-1 infectious clone
pMeHV1-C18. The genes affected and encoded gene products are shown
Gene/element Gene product/function pMeHV1-C18 GaHV-21 HHV-12 HHV-33 SuHV-14 BoHV-15
vLip Viral lipase NE NE NA NA NA NA
LORF2 Unknown NE E/NE NA NA NA NA
UL6 Portal protein E ND E E ND E
UL8 Helicase/ primase associated protein E ND E E ND E
UL9 Origin binding protein E ND E E E E
UL10 Glycoprotein M NE E NE E E NE
UL13 Protein kinase A NE NE NE NE NE
UL17 Tegument/DNA packaging protein E E E E E E
UL19 VP5 capsid protein E E E E NE E
UL21 Tegument protein A ND NE E NE NE
UL26 Scaffold protease E ND E E ND E
UL26.5 Scaffold protein E ND E E ND E
UL27 Glycoprotein B E* E E E ND E
UL29 Single stranded DNA binding protein E ND E E E E
UL36 Large tegument protein E E E E E E
UL37 Tegument protein E E E E ND E
UL39 Ribonucleotide reductase large subunit NE NE NE NE NE NE
UL40 Ribonucleotide reductase small subunit NE* ND NE NE ND NE
UL42 DNA polymerase processivity subfactor E ND E E ND E
UL47 VP13/14 capsid protein NE NE NE NE NE NE
UL48 VP16 α-transinducing factor NE NE E NE NE NE
UL52 Helicase/ primase associated protein E ND E E ND E
UL53 Glycoprotein K A E NE E E E
LORF4A Unknown NE ND NA NA NA NA
LORF5 Unknown NE# NE NA NA NA NA
icp4 Major immediate early regulatory gene E ND E E ND ND
US3 Protein kinase NE NE NE E NE NE
US6 Glycoprotein D NE* NE E ND NE E
The gene requirements for pMeHV1-C18 determined in this study are designated as either essential (E), non-essential (NE) or severely attenuated (A). Comparative
data, using the same nomenclature, is shown for selected alphaherpesviruses; Gallid herpesvirus 2 (GaHV-2), Human herpesvirus 1 (HHV-1), Human herpesvirus 3
(HHV-3), Suid herpesvirus 1 (SuHV-1) and Bovine herpesvirus 1 (BoHV-1). Not applicable (NA) denotes genes unique to the genus Mardivirus. Rows in bold highlight
those genes for which requirement varies between the viruses listed. *Requirement for growth in cell culture previously reported in wildtype MeHV-1
virus [57–59]
#Transposon was unstable in viral genome
References for gene interruption studies: 1[18, 23, 25, 42, 49, 57, 60–67]; 2[14, 35, 38, 58, 68–76]; 3[26, 41, 45, 77, 78]; 4[17, 27, 43, 48, 79–82]; 5[19, 83]
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The LORF5 gene was found to be non-essential for
viral replication in cell culture, since CPE was observed
for the disruption mutants pMeHV1-C18-MuAΔ59
and MuAΔ82. However, both mutants were observed
to partially lose eGFP expression by passage three in
cell culture, based on the presence of both eGFP
Fig. 1 Classification of the replication capacity of transposition mutants of MeHV-1 in cell culture. Gene requirements of MeHV-1 were assigned
based on the replication capacity of the respective transposition mutants in cell culture when compared to parental virus (MuAΔ65 day 5
post-transfection a: brightfield × 100; and b: fluorescent microscopy × 100). Clones were classified as ‘non-essential, no attenuation’ (MuAΔ72 day
5 post-transfection c: brightfield × 100; and d: fluorescent microscopy × 100), ‘non-essential, severe attenuation’ (MuAΔ68 day 7 post-transfection
e: brightfield × 100; and f: fluorescent microscopy × 100), or ‘essential, complete attenuation’ (MuAΔ64 day 7 post-transfection g: brightfield × 100;
and h: fluorescent microscopy × 100). BAC DNA encoding the MeHV-1 genome and containing a single transposon insertion within either the
BAC vector backbone, therefore reflecting parental virus (a and b), UL48 (c and d), UL53 (e and f) or UL27 (g and h) was transfected into CEFs.
Monolayers were passaged every five to eight days and were observed for the development of CPE using light microscopy (a, c, e and g) and,
whenever possible, for expression of a marker gene (eGFP) using fluorescent microscopy (b, d, f and h)
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expressing foci of CPE as expected, as well as non-
eGFP expressing foci.
Transposition into the US region
Two genes within the US region, US3 and US6, were
disrupted by transposon insertion events. Both insertion
locations were determined to be non-essential for
MeHV-1 replication in cell culture (Table 1).
Transposition into the IRS/TRS
As previously reported, the IRS/TRS of MeHV-1 were
transposed at higher frequency compared to the rest of
the viral genome [21]. Of the 76 pMeHV1-C18 transpos-
ition mutants generated, 22 (29 %) mapped to the IRS/TRS
regions of the genome. Eleven of these insertions were
within the icp4 coding region. Three clones, pMeHV1-
C18-Tn5Δ13, Tn5Δ21 and MuAΔ76, mapped within the
repeated segment of the US8 gene. The transposition
events in seven clones were mapped to non-coding
sequences of the IRS/TRS elements. The remaining clone,
pMeHV1-C18-MuAΔ46, contained a transposon insertion
within the dual-copy gene vNR13.
All insertions mapped to different nucleotide positions
within the IRS/TRS elements, demonstrating that these
clones originated from independent transposition events
(Additional file 1: Supplemental Table S1). Insertion
events generated using the Tn5 < KAN-2 > transposon
were mapped to a specific repeat based on the presence
of suitable restriction endonuclease (RE) cleavage sites
within both the transposon construct and the iBAC
(Fig. 2). Interestingly, of the 10 insertions generated by
Tn5 transposition that mapped to the IRS/TRS regions,
eight were within the TRS. Virus was successfully recov-
ered from all Tn5 transposon mutants with insertions in
the IRS/TRS. However, this did not reflect the require-
ment of the genetic elements at the location of the inser-
tion for viral replication, since the untransposed copy of
the gene may compensate for loss of the transposed
copy. Furthermore, it was anticipated that recombin-
ation between the IRS and TRS elements during viral
replication could result in the recovery of the parental
iBAC genotype (Fig. 2).
In an attempt to determine the requirement of dual-
copy genes, naturally occurring recombination between
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Fig. 2 Restriction fragment length polymorphism of icp4 insertion mutants a Schematic representation of the four potential genotypes resulting
from recombination between the IRS/TRS elements of pMeHV1-C18-Tn5Δ-1 during virus replication. Genotype 1: Transposon in TRS; Genotype 2:
Inversion of transposon to the IRS; Genotype 3: Duplication of transposon; Genotype 4: Loss of transposon. (b) In silico FseI/SbfI restriction
endonuclease digestion patterns for pMeHV1-C18-Tn5Δ1 Genotypes 1, 2, 3, and 4. (c) iBAC DNA co-digested with FseI and SbfI. lane 1:
pMeHV1-C18-Tn5Δ1 (genotype 1); lane 2: loss of transposon (genotype 4); lane 3: transposon in IRS element (genotype 2); lane 4: transposon in
TRS element (genotype 1); lane 5: duplication of transposon (genotype 3)
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the IRS/TRS elements during viral replication was
exploited to isolate double-insertional mutants [22]. This
was investigated using the icp4 disruption mutant,
pMeHV1-C18-Tn5Δ1. It was postulated that following
recovery of infectious MeHV-1 and subsequent viral rep-
lication, recombination between the IRS and TRS regions
during replication would result in the generation of four
genotypes as illustrated in Fig.2a. These genotypes were:
genotype 1, a single transposon insertion in the TRS as
described for pMeHV1-C18-Tn5Δ1; genotype 2, charac-
terised by an inversion of the repeat sequence elements,
transferring the original transposon insertion to the IRS
element; genotype 3, replacement of the unmodified IRS
with the transposed TRS sequence caused a duplication
of the TRS transposon element, thus generating a double
icp4 disruption mutant; or genotype 4, a duplication of
the IRS element eliminating the transposed TRS element,
thereby restoring the parental iBAC sequence. The
requirement of icp4 for replication can be assessed using
a genotype 3 construct, because of its icp4-negative
genotype (Fig.2a).
To determine which of these genotypes could be
recovered from cells infected with virus recovered from
pMeHV1-C18-Tn5Δ1, total DNA was isolated and elec-
troporated into bacterial cells. Putative iBAC DNA were
recovered from chloramphenicol resistant bacteria and
digested with FseI and SbfI. In silico analyses suggested
that double-digestion of Tn5 transposition mutants with
these restriction enzymes would generate fragment
profiles characteristic for the genotypes described previ-
ously (Fig.2b). All four genotypes could be distinguished
by the presence or absence of two polymorphic
fragments with a predicted size of ~12kbp and ~8.5kbp.
The RE patterns of five recovered pMeHV1-C18-Tn5Δ1
iBAC clones digested with FseI and SbfI are shown in
Fig.2c. The predicted polymorphic fragments generated by
the addition of the SbfI site by Tn5 transposition into the
TRS/IRS elements were clearly distinguishable, although
their estimated sizes were larger than expected (~14.1kbp
and ~12.5 kbp; Fig.2c). There are several factors that may
have retarded the migration of these fragments including
overloading of iBAC DNA, presence of impurities or
excess bacterial host DNA. All potential genotypes gener-
ated two large fragments, represented by the large fluores-
cent bands (Fig.2b and 2c), which are not individually
resolvable by standard agarose gel electrophoresis. The
predicted 3.7-kbp and 3.6-kbp fragments were not
observed in the electrophoretic analyses due to their
relatively small size; thus these fragments represented only
a very small proportion of the total DNA and their stain-
ing was expected to be beyond the limits of detection. As
these fragments were identical in all potential genotypes
and therefore visualisation of these fragments was not
necessary for evaluation of the assay.
Recovered clones that had the larger polymorphic
fragment were classified as genotype 1, while clones with
the smaller polymorphic fragment were identified as
genotype 2. Clones with both fragments were designated
as icp4-negative mutants (genotype 3). Clones with
neither of these fragments had reverted to the genotype
of the parental iBAC (genotype 4). Of the 41 clones
subjected to digestion with SbfI and FseI, 10 clones were
classified as genotype 1, 11 clones were genotype 2, five
clones were determined to be of genotype 3 and 10
clones were genotype 4. The RE fragment profiles of the
remaining five clones analysed were inconsistent with
the parental clone, pMeHV1-C18-Tn5Δ1, and were
discarded from further analyses.
One dual-icp4 disruption clone (genotype 3),
pMeHV1-C18-Tn5Δ1-3, was used to investigate the re-
quirement for icp4 for MeHV-1 replication in cell cul-
ture. Transfection of this construct into chicken embryo
fibroblasts (CEFs) did not result in any observable CPE
after three passages, demonstrating that icp4 is essential
for MeHV-1 replication in cell culture. Although the ap-
proach described above resulted in the isolation of a
dual-copy icp4 disruption mutant, it was not success-
fully applied to the isolation of dual-copy mutants for
other genes in IRS/TRS regions.
Transposition into the IRL/TRL
Two MuA transposon insertion events mapped to the non-
coding sequences of the IRL/TRL regions. Since insertions
events were isolated from MuA transposition reactions,
they could not be localised to individual repeats due to lack
of suitable RE sites in the transposon construct, and dual-
copy disruption mutants could not be not generated.
Transposition into a-like sequences
Two transposed clones, pMeHV1-C18-Tn5Δ16 and
Tn5Δ20, contained insertions within the a-like sequences
of the MeHV-1 genome (Additional file 1: Supplemental
Table S1). The exact nucleotide position of the insertion
could not be determined for these clones, since the
nucleotide sequence data did not extend beyond the
termini of this repetitive sequence element. Transfection
of Tn5Δ16, with a single transposon insertion into an
a-like sequence, produced CPE indistinguishable from that
of wild-type MeHV-1. However, because only one copy of
the a-like sequences was disrupted, the requirement of
these regions for replication of MeHV-1 in cell culture
could not be determined in the current study.
Discussion
The requirements for 28 coding and six non-coding regions
within the MeHV-1 genome have been determined in this
study, using a library of 76 transposition mutants. These
included 11 genes for which the in vitro requirements for
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replication have not previously been reported in any of the
mardiviruses (Table 1). Clones with unique phenotypes and
gene designations that contrast with the reported literature
are discussed in detail below. Of particular interest in this
study were those insertion sites that were non-essential for
replication, as these represent potential transgene insertion
sites for MeHV-1-based vectors. These sites included 14 in-
tragenic and six intergenic sites.
Homologues of the LORF2 gene are restricted to the
Mardivirus genus. It has been suggested that this gene
may have a role in mRNA transcription or processing
but this is yet to be experimentally confirmed [12].
Recently, the GaHV-2 LORF2 homologue was reported
to have immunoevasion functions via the down-
regulation of MHC class I in infected cells [23]. LORF2
has previously been reported as essential for GaHV-2
replication in cell culture [18]. In contrast, another study
reported retroviral insertions within the ORF as having
no effect on GaHV-2 replication [23, 24]. In the current
study, transposition clone MuAΔ30 contained an inser-
tion within the first exon of MeHV-1 LORF2, disrupting
99.5 % of the predicted polypeptide. Viral recovery
experiments clearly demonstrated that this location was
non-essential for replication of MeHV-1 in cell culture,
with CPE developing within five days of transfection. The
differing requirement of this gene in MeHV-1 and GaHV-
2 is of interest, and further investigations into LORF2
function in MeHV-1 are warranted. Furthermore, the use
of LORF2 as a transgene insertion site for vaccine develop-
ment may increase vaccine efficacy through impairment of
the proposed LORF2 immunoevasion functions.
The non-essential classification of MeHV-1 UL10 in
this study contrasts with the essential assignment of the
GaHV-2 UL10 homologue (Table 1) [25]. The UL10
gene encodes a homologue of glycoprotein M (gM), a
core herpesvirus gene [11, 12]. The UL10 gene is essen-
tial in the strictly cell-associated viruses GaHV-2 and
Human herpesvirus 3 (HHV-3) [25, 26]. In contrast,
UL10 has consistently been reported as non-essential for
viral replication in cell culture for cell-free herpesviruses
such as HHV-1, Suid herpesvirus 1 (SuHV-1), Bovine
herpesvirus 1 (BoHV-1), Equine herpesvirus 1 (EHV-1)
and Gallid herpesvirus 1 [19, 27–30]. Although the
parental MeHV-1 strain FC126 used in this study was
cell-associated, cell-free virus is produced to a limited
extent and this strain can be adapted to produce high
titres of cell-free virus [31]. It has also been suggested
that expression of glycoprotein D (gD) may compensate
for loss of gM function, since both HHV-3 and GaHV-2
do not express gD in cell culture, and this may explain
the essential designation of gM in these viruses [25].
While the expression of MeHV-1 gD during infection in
cell culture has not been reported to date, the capacity
of the virus to adapt to cell-free growth suggests it is.
The UL21 gene encodes a poorly characterised
tegument protein that is capsid-associated and may have
roles in intracellular transport and in nuclear egress
[32, 33]. The recovery of infectious MeHV-1 from three
UL21 transposed clones, Tn5Δ14, MuAΔ37 and MuAΔ41,
in combination with the presence of viral DNA after
sequential passages, confirms that MeHV-1 UL21 is non-
essential for replication in cell culture. However, replica-
tion was severely attenuated compared to the parent virus.
Disruption studies in other alphaherpesviruses have
shown UL21 to be non-essential, although a range of
deleterious effects have been noted on virus replication
(Table 1). A UL21 mutant of SuHV-1 showed impaired
replication in cell culture and reduced virulence in vivo
[17, 34]. For HHV-1 and BoHV-1, UL21 has been shown
to be non-essential, but deletion reduced the in vivo
replication capacity of HHV-1 [19, 35, 36]. In contrast,
UL21 has been reported to be essential for Human her-
pesvirus 2, HHV-3 and EHV-1 [26, 32, 37]. The severe
attenuation observed for MeHV-1 in this study suggests
the UL21 gene is unsuitable for use in recombinant vac-
cine applications, however it may be of use for generat-
ing replication-limited gene delivery constructs for
poultry research applications.
The non-essential phenotype of MeHV-1 UL48 disrup-
tion mutants characterised in this study conflicts with the
essential requirement of this gene for HHV-1 replication
(Fig.1c and 1d). In HHV-1, UL48 encodes the VP16
α-trans inducing factor, a tegument protein that induces
immediate-early gene transcription and is also required
for virion assembly [38]. The UL48 homologues of many
alphaherpesviruses, including mardiviruses, lack the acidic
carboxyl terminus transactivating domain present in the
HHV-1 UL48 protein, however transactivating functions
may be retained via other transactivation sites within
UL48 [11, 12, 39, 40]. This gene is essential for the replica-
tion of HHV-1 and EHV-1 in cell culture, but is non-
essential in other alphaherpesviruses investigated to date,
including HHV-3, SuHV-1, BoHV-1 and GaHV-2 (Table 1)
[19, 26, 38, 41–45].
The MeHV-1 UL53 gene is a homologue of the HHV-1
gene encoding glycoprotein K (gK) [11, 12]. Similar to
other viral glycoproteins, gK has roles in cell-to-cell fusion
and in viral egress from infected cells [46, 47]. It has been
reported to be essential for replication of many alphaher-
pesviruses, including GaHV-2, HHV-3, SuHV-1 and
BoHV-1 (Table 1) [19, 26, 48, 49], while it is non-essential
for HHV-1 and EHV-1 growth in vivo [50, 51]. Interest-
ingly, deletion of UL53 from both the HHV-1 and EHV-1
genomes resulted in severely attenuated viruses with
greatly reduced plaque sizes and impaired virion penetra-
tion in cell culture [37, 51, 52]. Marked attenuation was
also observed for the MeHV-1 UL53 disruption mutant,
MuAΔ68, in this study (Fig.1e and 1f).
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The MeHV-1 LORF4A gene is a homologue of LORF4
genes of GaHV-2 and GaHV-3 and LORF9 of Anatid
herpesvirus 1, and the encoded polypeptide shares 47 %
amino acid identity to the proposed paralogue, MeHV-1
LORF4 [11, 12]. The LORF4 homologues have been
postulated to have roles as avian host range determi-
nants, since the occurrence of this gene is restricted to
mardiviruses [11, 12]. Transposon insertion into
LORF4A in the pMeHV1-C18 transposon clone Tn5Δ10
disrupted 82 % of the gene, and the insertion location
was designated as non-essential for virus growth in cell
culture. This is the first report of a disruption mutant of
LORF4.
Overall fourteen genetic locations were identified as
essential for MeHV-1 replication in cell culture (Table 1).
The classification of these loci provides additional founda-
tional information concerning MeHV-1 replication, as the
requirements of 13 of these genes have not previously
been reported for MeHV-1. Although it would have been
interesting to determine the effects of insertions on global
viral gene expression and protein production, this was
beyond the scope of the current study. Similarly, revertant
constructs were not generated for replication-defective
mutants since putatively essential genes are not of further
interest for vaccine development.
It is noteworthy that the transposition mutants reported
here are cumulative gene deletion mutants of MeHV-1, as
pMeHV1-C18 lacks seven coding regions compared to
the parental virus [20]. This genetic background may have
contributed to the observed attenuation of some clones
compared to the wild-type MeHV-1. It is considered
unlikely that the requirement of the non-essential loci
identified in this study would be essential in the full-
length virus, as it is reasonable to conclude that effects on
viral replication are likely to be more severe with cumula-
tive gene deletions compared to the disruption of a single
gene. However, it is possible the locations designated as
essential in this study may be non-essential in the parental
virus. Nonetheless, this is also considered unlikely as the
MeHV-1 genes designated as essential in this study
conform with the reported requirements for the respective
homologues of other alphaherpesviruses, with the excep-
tion of UL19 which is reported as non-essential in SuHV-
1 (Table 1) [17]. However, it must be noted that in that
study, the transposon insertion event mapped 2 bp down-
stream of the SuHV-1 UL19 ORF, therefore it could be
argued that this was not a true report of the UL19 require-
ment in this virus as complete translation of the encoded
polypeptide would have been possible.
Given the instability observed in the LORF5 insertion
mutants, it is possible that this is an essential gene and
it may have been misclassified as non-essential in the
current study. This is considered unlikely, since in the
case of the LORF5 mutants, the transgene was gradually
lost during serial passage of recovered virus. In the case
of an insertion into an essential gene, the insertion
mutant would not undergo sufficient replication capacity
to facilitate loss of the transgene and subsequent recov-
ery of virus. Regardless of whether the LORF5 gene is
essential or non-essential for replication, the observed
instability of the transposon insertions in two independ-
ent LORF5 transposon insertion mutants suggests this
region of the genome would be unsuitable for recombin-
ant vector applications.
Despite the potential limitations of the cumulative gene
deletion genotype of the iBAC used in this study, it has
enabled the identification of viruses with novel pheno-
types, for example the MuAΔ68 virus with an insertion
into UL53. While CPE was observed, it was subtle com-
pared to the parent virus and may have been missed com-
pletely in the absence of reporter gene expression (Fig.1e
and 1f). It is considered highly unlikely that a virus with
this phenotype could be constructed using rational gene-
targeting strategies.
Importantly, potential insertion sites for vector develop-
ment must also be verified in vivo, since it is generally
accepted that non-essential genes in cell culture may have
major roles in vivo, for example in immunoevasion or
other virus-host interactions [14]. An example of this are
glycoprotein C (gC)-null mutants of GaHV-2, which show
increased viral replication in cultured cells, however in
vivo infection required a longer incubation period to
establish infection, viraemia and induction of seroconver-
sion compared to gC-positive virus, and gC-null viruses
were not transmitted horizontally [53, 54]. The in vivo
replication capacity of virus recovered from the parental
iBAC used in this study is reduced compared to wild-type
MeHV-1 [20]. As a result it might be expected that any
constructs derived from this parent clone would be fur-
ther attenuated in vivo. Extrapolating from the GaHV-2
studies discussed above, a deletion identified in the UL44
region of pMeHV1-C18 likely contributes to the in vivo
attenuation observed with this construct. Therefore
consideration should be given to the restoration of this
deletion prior to in vivo assessment of the non-essential
gene mutants constructed in the current study.
The strategy used to determine the replication require-
ment for icp4 highlights the power of iBAC technologies,
for example to generate a dual-disruption mutant with
two mutagenised copies of a repeat element. This strategy
was developed after the generation of the transposition
libraries, thus the presence of suitable RE sites in the Tn5
transposon and the virus was serendipitous. Future studies
investigating genetic elements located in the repeat
sequences of herpesvirus iBACs should consider the
identification of suitable RE sites within the targeted viral
genome to enable the identification of modified specific
repeat sequences. If appropriate sites are identified in the
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virus, complementary sites could be readily incorporated
into the proposed transgene molecule to facilitate the
isolation of double-deletion/disruption mutants.
Conclusions
Despite the previously reported resistance of the MeHV-1
genome to transposition [21], characterisation of mutant
clones obtained using these methods has enabled deter-
mination of twenty non-essential genomic locations.
When considered together with the parent genotype of
the MeHV-1 iBAC used in this study, these results
demonstrate the considerable degree of redundancy of
genes within the MeHV-1 genome in vitro. Moreover, the
genotype of pMeHV1-C18, containing multiple deletions
compared to the reference MeHV-1 genome, has enabled
the identification of viruses with unique phenotypes, such
as the gK and UL21 disruption viruses, which replicated
in the virtual absence of CPE. Of interest in future studies
would be the sequential restoration of genes into these
replication-impaired viruses to determine which genes
restore the capacity of recovered virus to cause a CPE
more characteristic of MeHV-1.
Methods
Transposition libraries
Construction and characterisation of the MeHV-1 iBAC
clone, pMeHV1-C18, is described in Mahony et al. [20].
This iBAC contains cumulative gene deletions compared
to the MeHV-1 FC126 strain, along with BAC vector
sequences within the SORF3/US2 region, and is genetic-
ally defined as pMeHV1-C18ΔUL43:UL44:UL45:UL56:
pp38:SORF3:US2, however the short form (pMeHV1-
C18) will be retained in this manuscript for simplicity.
The generation of pMeHV-C18 transposition clones
characterised in this study was reported previously [21].
Restriction endonuclease analyses
Double digestion of Tn5-transposition mutants was per-
formed with SbfI and FseI at 37 °C for 1 h, and reactions
were heat-inactivated at 65 °C for 20 min. Digestion prod-
ucts were resolved at 60 V for 3 h in 0.7 % agarose gels in
1 × Tris-acetate-EDTA buffer containing 0.1 μg mL−1
ethidium bromide. Banding patterns were visualised using
UV light.
Identification of transposition insertion site and
orientation
To identify transposon insertion location within the par-
ent iBAC, bi-directional sequencing was performed
using primers specific for the respective transposons
(Additional file 1: Supplemental Table S2). Data were
analysed using 4Peaks software (http://www.mekentosj.-
com/science/4peaks) and mapped to the MeHV-1 gen-
ome using Blastn analyses [55].
Growth of pMeHV1-C18 transposition mutants in
cell culture
To assess the capacity of the transposed clones to facilitate
the recovery of infectious MeHV-1, DNA was prepared
from transposon clones and transfected into CEFs. The
CEF cells were maintained in a 5 % CO2 environment at
37 °C in Medium 199 (Gibco), containing 10 % foetal bo-
vine serum (Gibco) and 1 ×Antibiotic-Antimycotic (Gibco).
Recovered iBAC DNA was transfected in triplicate into
CEFs at 80 % confluency, using Lipofectamine and Plus
reagent (Invitrogen) according to manufacturer’s instruc-
tions. Recovery of virus was assessed on a daily basis for
characteristic MeHV-1 CPE using light microscopy, and
where possible, by the presence of eGFP expression using
fluorescent microscopy. Monolayers were passaged at least
once after CPE was evident to confirm the presence of
passageable virus. Monolayers in which CPE was not
observed, were blind passaged after five to eight days at
least three times to confirm the absence of infectious
MeHV-1.
Analyses of UL21 disruption mutants
PCR for detection of UL21 insertion clones was performed
on total DNA harvested from infected cultures at the third
or sixth passage, as described previously [56]. Total DNA
was extracted using the DNeasy blood and tissue kit
(Qiagen). Elute (2 μL) was used as a template for PCR over
the UL21 coding region using oligonucleotide pairs:
HVT27Fwd with HVTFrag5Rev, HVT27Fwd with KanME-
Rev, and KanME-Fwd with HVTFrag5Rev (Additional file
1: Supplemental Table S2). Each 50 μL PCR reaction con-
tained 1 × PCR buffer – Mg (Invitrogen), 0.2 mM each
dNTP, 1.5 mM MgCl2, 0.2 μM each primer, 1 U Platinum
Taq DNA polymerase (Invitrogen) and 2 μL template.
Cycling conditions were: 94 °C for 2 min followed by 30 cy-
cles of 94 °C for 30 s, 55 °C for 30 s, 72 °C for 1 min per
kbp. PCR products (5 μL) were resolved on 1 % agarose
gels containing GelRed at 60 V for 1 to 1.5 h.
Characterisation of transposition events in genomic
repeat regions
BACs were re-isolated from cultures infected with the
Tn5 mutant pMeHV1-C18-Tn5Δ1, containing a trans-
poson insertion within the IRS copy of icp4. Briefly, total
DNA was extracted from cultures four days after the third
passage, as described previously [56]. Purified DNA (1 μg)
was electroporated into 50 μl of Electromax DH10B E. coli
(Invitrogen) and selected for on Luria-Bertani (LB) agar
plates containing either 12.5 μg mL−1 chloramphenicol
alone, or with the addition of 30 μg mL−1 kanamycin.
Antibiotic-resistant colonies containing an iBAC construct
were isolated, and DNA was extracted and double-digested
with FseI and SbfI as described above. A genomic sequence
for pMeHV1-C18-Tn5Δ1 was generated in silico by
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insertion of the Tn5 transposon sequence to simulate the
TRS insertion genotype. Analogous genomic sequences
were also generated for clones with the IRS insertion and
the IRS/TRS dual insertion genotypes. Selected clones
representing the dual-icp4 deletion genotype were identi-
fied by restriction endonuclease digestion and subsequently
transfected back into CEFs, and cultures were monitored
for the development of CPE.
Additional file
Additional file 1: Supplemental Table S1. Details of transposon gene
interruptions into the MeHV-1 infectious clone pMeHV1-C18. Supplemental
Table S2: Oligonucleotides used in this study. Supplemental Figure S1:
Primary chicken embryo fibroblasts (CEFs) were used as a negative control.
(PDF 121 kb)
Abbreviations
BoHV-1: Bovine herpesvirus 1; CEFs: Chicken embryo fibroblasts;
CPE: Cytopathic effect; EHV-1: Equine herpesvirus 1; eGFP: Enhanced green
fluorescent protein; GaHV-2: Gallid herpesvirus 2; GaHV-3: Gallid herpesvirus
3; gC: Glycoprotein C; gD: Glycoprotein D; gE: Glycoprotein E;
gK: Glycoprotein K; gM: Glycoprotein M; HHV-1: Human herpesvirus 1;
HHV-3: Human herpesvirus 3; HVT: Turkey herpesvirus; iBAC: Infectious
bacterial artificial chromosome; IRL: Internal repeat long; IRS: Internal repeat
short; MD: Marek’s disease; MeHV-1: Meleagrid herpesvirus 1; RE: Restriction
enzyme; SuHV-1: Suid herpesvirus 1; TRL: Terminal repeat long; TRS: Terminal
repeat short; UL: Unique long; US: Unique short.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
RNH participated in design of the study, carried out the molecular studies
and drafted the manuscript. JM and EVF participated in design of the study
and critical revision of the manuscript. TJM conceived the study, and
participated in its design and coordination and assisted with drafting the
manuscript. All authors read and approved the final manuscript.
Acknowledgements
This research was funded by Poultry CRC, established and supported under the
Australian Government’s Cooperative Research Centres Program. RNH was
supported by an Australian Postgraduate Award and by the Poultry CRC. The
authors wish to thank Michael Frese for critical revision of the manuscript.
Author details
1School of Veterinary Science, The University of Queensland, Gatton, QLD
4343, Australia. 2Poultry CRC, University of New England, Armidale, NSW
2351, Australia. 3Present address: Commonwealth Scientific and Industrial
Research Organisation – Biosecurity Flagship, Black Mountain 2601, Australia.
4Animal Science, Department of Agriculture, Fisheries and Forestry, Brisbane,
QLD 4072, Australia. 5Queensland Alliance for Agriculture and Food
Innovation, Centre for Animal Science, The University of Queensland,
Brisbane, QLD 4072, Australia.
Received: 26 June 2015 Accepted: 17 August 2015
References
1. Kawamura H, King Jr DJ, Anderson DP. A herpesvirus isolated from kidney
cell culture of normal turkeys. Avian Dis. 1969;13:853–63.
2. Witter RL, Nazerian K, Purchase HG, Burgoyne GH. Isolation from turkeys of a
cell-associated herpesvirus antigenically related to Marek's disease virus. Adv
Virus Res. 1970;31:525–38.
3. Okazaki W, Purchase HG, Burmester BR. Protection against Marek's disease
by vaccination with a herpesvirus of turkeys. Avian Dis. 1970;14:413–29.
4. Eidson CS, Ellis MN, Kleven SH. Reduced vaccinal protection of turkey
herpesvirus against field strains of Marek's disease herpesvirus. Poult Sci.
1981;60:317–22.
5. Witter RL. Increased virulence of Marek's disease virus field isolates. Avian
Dis. 1997;41:149–63.
6. Palya V, Kiss I, Tatar-Kis T, Mato T, Felfoldi B, Gardin Y. Advancement in
vaccination against Newcastle disease: recombinant HVT NDV provides high
clinical protection and reduces challenge virus shedding with the absence
of vaccine reactions. Avian Dis. 2012;56:282–7.
7. Le Gros FX, Dancer A, Giacomini C, Pizzoni L, Bublot M, Graziani M, et al.
Field efficacy trial of a novel HVT-IBD vector vaccine for 1-day-old broilers.
Vaccine. 2009;27:592–6.
8. Johnson DI, Vagnozzi A, Dorea F, Riblet SM, Mundt A, Zavala G, et al.
Protection against infectious laryngotracheitis by in ovo vaccination with
commercially available viral vector recombinant vaccines. Avian Dis.
2010;54:1251–9.
9. Rauw F, Palya V, Van Borm S, Welby S, Tatar-Kis T, Gardin Y, et al. Further
evidence of antigenic drift and protective efficacy afforded by a recombinant
HVT-H5 vaccine against challenge with two antigenically divergent Egyptian
clade 2.2.1 HPAI H5N1 strains. Vaccine. 2011;29:2590–600.
10. Gao H, Cui H, Cui X, Shi X, Zhao Y, Zhao X, et al. Expression of HA of HPAI
H5N1 virus at US2 gene insertion site of turkey herpesvirus induced better
protection than that at US10 gene insertion site. PLoS One.
2011;6, e22549.
11. Afonso CL, Tulman ER, Lu Z, Zsak L, Rock DL, Kutish GF. The genome of
turkey herpesvirus. J Virol. 2001;75:971–8.
12. Kingham BF, Zelník V, Kopáček J, Majerciak V, Ney E, Schmidt CJ. The
genome of herpesvirus of turkeys: comparative analysis with Marek's disease
viruses. J Gen Virol. 2001;82:1123–35.
13. Spatz SJ, Silva RF. Polymorphisms in the repeat long regions of oncogenic
and attenuated pathotypes of Marek's disease virus 1. Virus Genes.
2007;35:41–53.
14. Fields BN, Knipe DM, Howley PM. Fields' virology. 5th ed. Philadelphia:
Wolters Kluwer/Lippincott Williams & Wilkins; 2007.
15. Weber P, Levine M, Glorioso J. Rapid identification of nonessential genes of
herpes simplex virus type 1 by Tn5 mutagenesis. Science. 1987;236:576–9.
16. Brune W, Menard C, Hobom U, Odenbreit S, Messerle M, Koszinowski UH.
Rapid identification of essential and nonessential herpesvirus genes by
direct transposon mutagenesis. Nat Biotechnol. 1999;17:360–4.
17. Smith GA, Enquist LW. Construction and transposon mutagenesis in
Escherichia coli of a full-length infectious clone of pseudorabies virus, an
alphaherpesvirus. J Virol. 1999;73:6405–14.
18. Chattoo JP, Stevens MP, Nair V. Rapid identification of non-essential genes
for in vitro replication of Marek's disease virus by random transposon
mutagenesis. J Virol Methods. 2006;135:288–91.
19. Robinson KE, Meers J, Gravel JL, McCarthy FM, Mahony TJ. The essential and
non-essential genes of bovine herpesvirus 1. J Gen Virol. 2008;89:2851–63.
20. Mahony TJ, Hall RN, Walkden-Brown S, Meers J, Gravel JL, West L, et al.
Genomic deletions and mutations resulting in the loss of eight genes
reduce the in vivo replication capacity of Meleagrid herpesvirus 1. Virus
Genes. 2015;51:85–95.
21. Hall RN, Meers J, Mitter N, Fowler EV, Mahony TJ. The meleagrid herpesvirus
1 genome is partially resistant to transposition. Avian Dis. 2013;57:380–6.
22. Borst EM, Hahn G, Koszinowski UH, Messerle M. Cloning of the human
cytomegalovirus (HCMV) genome as an infectious bacterial artificial
chromosome in Escherichia coli: a new approach for construction of HCMV
mutants. J Virol. 1999;73:8320–9.
23. Hearn C, Preeyanon L, Hunt HD, York IA. An MHC class I immune evasion
gene of Mareks disease virus. Virology. 2015;475:88–95.
24. Isfort R, Jones D, Kost R, Witter R, Kung HJ. Retrovirus insertion into
herpesvirus in vitro and in vivo. Proc Natl Acad Sci U S A. 1992;89:991–5.
25. Tischer BK, Schumacher D, Messerle M, Wagner M, Osterrieder N. The
products of the UL10 (gM) and the UL49.5 genes of Marek's disease virus
serotype 1 are essential for virus growth in cultured cells. J Gen Virol.
2002;83:997–1003.
26. Zhang Z, Selariu A, Warden C, Huang G, Huang Y, Zaccheus O, et al.
Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic
factor. PLoS Pathog. 2010;6, e1000971.
27. Dijkstra JM, Visser N, Mettenleiter TC, Klupp BG. Identification and
characterization of pseudorabies virus glycoprotein gM as a nonessential
virion component. J Virol. 1996;70:5684–8.
Hall et al. Virology Journal  (2015) 12:130 Page 10 of 12
28. Fuchs W, Mettenleiter TC. DNA sequence of the UL6 to UL20 genes of infectious
laryngotracheitis virus and characterization of the UL10 gene product as a
nonglycosylated and nonessential virion protein. J Gen Virol. 1999;80:2173–82.
29. Seyboldt C, Granzow H, Osterrieder N. Equine herpesvirus 1 (EHV-1)
glycoprotein M: effect of deletions of transmembrane domains. Virology.
2000;278:477–89.
30. Baines JD, Roizman B. The open reading frames UL3, UL4, UL10, and UL16
are dispensable for the replication of herpes simplex virus 1 in cell culture.
J Virol. 1991;65:938–44.
31. Yachida S, Kondo T, Hirai K, Izawa H, Mikami T. Establishment of a variant
type of turkey herpesvirus which releases cell-free virus into the culture
medium in large quantities. Arch Virol. 1986;91:183–92.
32. Le Sage V, Jung M, Alter JD, Wills EG, Johnston SM, Kawaguchi Y, et al. The
herpes simplex virus type 2 UL21 protein is essential for virus propagation.
J Virol. 2013;87:5904–15.
33. Takakuwa H, Goshima F, Koshizuka T, Murata T, Daikoku T, Nishiyama Y.
Herpes simplex virus encodes a virion-associated protein which promotes
long cellular processes in over-expressing cells. Genes Cells. 2001;6:955–66.
34. de Wind N, Wagenaar F, Pol J, Kimman T, Berns A. The pseudorabies virus
homology of the herpes simplex virus UL21 gene product is a capsid
protein which is involved in capsid maturation. J Virol. 1992;66:7096–103.
35. Baines JD, Koyama AH, Huang T, Roizman B. The UL21 gene products of
herpes simplex virus 1 are dispensable for growth in cultured cells. J Virol.
1994;68:2929–36.
36. Muto Y, Goshima F, Ushijima Y, Kimura H, Nishiyama Y. Generation and
characterization of UL21-null herpes simplex virus type 1. Front Microbiol.
2012;3:394.
37. Hansen K, Napier I, Koen M, Bradford S, Messerle M, Bell E, et al. In vitro
transposon mutagenesis of an equine herpesvirus 1 genome cloned as a
bacterial artificial chromosome. Arch Virol. 2006;151:2389–405.
38. Weinheimer SP, Boyd BA, Durham SK, Resnick JL, O'Boyle 2nd DR. Deletion
of the VP16 open reading frame of herpes simplex virus type 1. J Virol.
1992;66:258–69.
39. Yanagida N, Yoshida S, Nazerian K, Lee LF. Nucleotide and predicted amino
acid sequences of Marek's disease virus homologues of herpes simplex virus
major tegument proteins. J Gen Virol. 1993;74:1837–45.
40. Kopáček J, Zelník V, Koptidesová D, Pastoreková S, Pastorek J, Brasseur R, et
al. Herpesvirus of turkeys homologue of HSV VP16 is structurally related to
varicella zoster virus trans-inducing protein encoded by ORF10. Virus Genes.
1997;15:45–52.
41. Cohen JI, Seidel K. Varicella-zoster virus (VZV) open reading frame 10
protein, the homolog of the essential herpes simplex virus protein VP16, is
dispensable for VZV replication in vitro. J Virol. 1994;68:7850–8.
42. Dorange F, Tischer BK, Vautherot J-F, Osterrieder N. Characterization of
Marek's disease virus serotype 1 (MDV-1) deletion mutants that lack UL46 to
UL49 genes: MDV-1 UL49, encoding VP22, is indispensable for virus growth.
J Virol. 2002;76:1959–70.
43. Fuchs W, Granzow H, Klupp BG, Kopp M, Mettenleiter TC. The UL48
tegument protein of pseudorabies virus is critical for intracytoplasmic
assembly of infectious virions. J Virol. 2002;76:6729–42.
44. von Einem J, Schumacher D, O'Callaghan DJ, Osterrieder N. The alpha-TIF
(VP16) homologue (ETIF) of equine herpesvirus 1 is essential for secondary
envelopment and virus egress. J Virol. 2006;80:2609–20.
45. Che X, Reichelt M, Sommer MH, Rajamani J, Zerboni L, Arvin AM. Functions
of the ORF9-to-ORF12 gene cluster in varicella-zoster virus replication and in
the pathogenesis of skin infection. J Virol. 2008;82:5825–34.
46. Hutchinson L, Goldsmith K, Snoddy D, Ghosh H, Graham FL, Johnson DC.
Identification and characterization of a novel herpes simplex virus
glycoprotein, gK, involved in cell fusion. J Virol. 1992;66:5603–9.
47. Hutchinson L, Johnson DC. Herpes simplex virus glycoprotein K promotes
egress of virus particles. J Virol. 1995;69:5401–13.
48. Klupp BG, Baumeister J, Dietz P, Granzow H, Mettenleiter TC. Pseudorabies
virus glycoprotein gK is a virion structural component involved in virus
release but is not required for entry. J Virol. 1998;72:1949–58.
49. Osterrieder K, Vautherot J-F. The genome content of Marek's
disease-like viruses. In: Davison F, Nair V, editors. In Marek's Disease:
An Evolving Problem. Oxford: Academic; 2004. p. 17–31.
50. Jons A, Dijkstra JM, Mettenleiter TC. Glycoproteins M and N of pseudorabies
virus form a disulfide-linked complex. J Virol. 1998;72:550–7.
51. Jayachandra S, Baghian A, Kousoulas KG. Herpes simplex virus type 1
glycoprotein K is not essential for infectious virus production in actively
replicating cells but is required for efficient envelopment and translocation
of infectious virions from the cytoplasm to the extracellular space. J Virol.
1997;71:5012–24.
52. Neubauer A, Osterrieder N. Equine herpesvirus type 1 (EHV-1) glycoprotein
K is required for efficient cell-to-cell spread and virus egress. Virology.
2004;329:18–32.
53. Tischer BK, Schumacher D, Chabanne-Vautherot D, Zelník V, Vautherot JF,
Osterrieder N. High-level expression of Marek's disease virus glycoprotein
C is detrimental to virus growth in vitro. J Virol. 2005;79:5889–99.
54. Jarosinski KW, Osterrieder N. Further analysis of Marek's disease virus
horizontal transmission confirms that U(L)44 (gC) and U(L)13 protein kinase
activity are essential, while U(S)2 is nonessential. J Virol.
2010;84:7911–6.
55. Zhang Z, Schwartz S, Wagner L, Miller W. A greedy algorithm for aligning
DNA sequences. J Comput Biol. 2000;7:203–14.
56. Morgan RW, Cantello JL, McDermott CH. Transfection of chicken embryo
fibroblasts with Marek's disease virus DNA. Avian Dis. 1990;34:345–51.
57. Isfort RJ, Qian Z, Jones D, Silva RF, Witter R, Kung HJ. Integration of multiple
chicken retroviruses into multiple chicken herpesviruses: herpesviral gD as a
common target of integration. Virology. 1994;203:125–33.
58. Darteil R, Bublot M, Laplace E, Bouquet JF, Audonnet JC, Riviere M.
Herpesvirus of turkey recombinant viruses expressing infectious bursal
disease virus (IBDV) VP2 immunogen induce protection against an IBDV
virulent challenge in chickens. Virology. 1995;211:481–90.
59. Baigent SJ, Petherbridge LJ, Smith LP, Zhao Y, Chesters PM, Nair VK.
Herpesvirus of turkey reconstituted from bacterial artificial chromosome
clones induces protection against Marek's disease. J Gen Virol.
2006;87:769–76.
60. Sakaguchi M, Urakawa T, Hirayama Y, Miki N, Yamamoto M, Zhu GS, et al.
Marek's disease virus protein kinase gene identified within the short unique
region of the viral genome is not essential for viral replication in cell culture
and vaccine-induced immunity in chickens. Virology. 1993;195:140–8.
61. Anderson AS, Parcells MS, Morgan RW. The glycoprotein D (US6) homolog
is not essential for oncogenicity or horizontal transmission of Marek's
disease virus. J Virol. 1998;72:2548–53.
62. Schumacher D, Tischer BK, Fuchs W, Osterrieder N. Reconstitution of Marek's
disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial
chromosome and characterization of a glycoprotein B-negative MDV-1
mutant. J Virol. 2000;74:11088–98.
63. Schumacher D, Tischer BK, Reddy SM, Osterrieder N. Glycoproteins E and I
of Marek's disease virus serotype 1 are essential for virus growth in cultured
cells. J Virol. 2001;75:11307–18.
64. Kamil JP, Tischer BK, Trapp S, Nair VK, Osterrieder N, Kung HJ. vLIP, a viral
lipase homologue, is a virulence factor of Marek's disease virus. J Virol.
2005;79:6984–96.
65. Blondeau C, Chbab N, Beaumont C, Courvoisier K, Osterrieder N, Vautherot
JF, et al. A full UL13 open reading frame in Marek's disease virus (MDV) is
dispensable for tumor formation and feather follicle tropism and cannot
restore horizontal virus transmission of rRB-1B in vivo. Vet Res.
2007;38:419–33.
66. Chbab N, Chabanne-Vautherot D, Francineau A, Osterrieder N, Denesvre
C, Vautherot JF. The Marek's disease virus (MDV) protein encoded by
the UL17 ortholog is essential for virus growth. Vet Res.
2009;40:28.
67. Sun A, Lee LF, Khan OA, Heidari M, Zhang H, Lupiani B, et al. Deletion of
Marek's disease virus large subunit of ribonucleotide reductase impairs virus
growth in vitro and in vivo. Avian Dis. 2013;57:464–8.
68. Goldstein DJ, Weller SK. Herpes simplex virus type 1-induced ribonucleotide
reductase activity is dispensable for virus growth and DNA synthesis:
isolation and characterization of an ICP6 lacZ insertion mutant. J Virol.
1988;62:196–205.
69. Ligas MW, Johnson DC. A herpes simplex virus mutant in which
glycoprotein D sequences are replaced by beta-galactosidase sequences
binds to but is unable to penetrate into cells. J Virol. 1988;62:1486–94.
70. Malik AK, Martinez R, Muncy L, Carmichael EP, Weller SK. Genetic analysis of
the herpes simplex virus type 1 UL9 gene: isolation of a LacZ insertion
mutant and expression in eukaryotic cells. Virology. 1992;190:702–15.
71. Purves FC, Spector D, Roizman B. UL34, the target of the herpes simplex
virus U(S)3 protein kinase, is a membrane protein which in its
unphosphorylated state associates with novel phosphoproteins. J Virol.
1992;66:4295–303.
Hall et al. Virology Journal  (2015) 12:130 Page 11 of 12
72. Coulter LJ, Moss HW, Lang J, McGeoch DJ. A mutant of herpes simplex virus
type 1 in which the UL13 protein kinase gene is disrupted. J Gen Virol.
1993;74(Pt 3):387–95.
73. Balan P, Davis-Poynter N, Bell S, Atkinson H, Browne H, Minson T. An
analysis of the in vitro and in vivo phenotypes of mutants of herpes simplex
virus type 1 lacking glycoproteins gG, gE, gI or the putative gJ. J Gen Virol.
1994;75:1245–58.
74. Martin DW, Weber PC. The a sequence is dispensable for isomerization of
the herpes simplex virus type 1 genome. J Virol. 1996;70:8801–12.
75. Salmon B, Cunningham C, Davison AJ, Harris WJ, Baines JD. The herpes
simplex virus type 1 U(L)17 gene encodes virion tegument proteins that are
required for cleavage and packaging of viral DNA. J Virol. 1998;72:3779–88.
76. Desai P, Sexton GL, McCaffery JM, Person S. A null mutation in the gene
encoding the herpes simplex virus type 1 UL37 polypeptide abrogates virus
maturation. J Virol. 2001;75:10259–71.
77. Mallory S, Sommer M, Arvin AM. Analysis of the glycoproteins I and E of
varicella-zoster virus (VZV) using deletional mutations of VZV cosmids.
J Infect Dis. 1998;178:22–6.
78. Sato B, Ito H, Hinchliffe S, Sommer MH, Zerboni L, Arvin AM. Mutational
analysis of open reading frames 62 and 71, encoding the varicella-zoster
virus immediate-early transactivating protein, IE62, and effects on replication
in vitro and in skin xenografts in the SCID-hu mouse in vivo. J Virol.
2003;77:5607–20.
79. de Wind N, Zijderveld A, Glazenburg K, Gielkens A, Berns A. Linker insertion
mutagenesis of herpesviruses: inactivation of single genes within the Us
region of pseudorabies virus. J Virol. 1990;64:4691–6.
80. Hanssens FP, Nauwynck HJ, Mettenleiter TC. Role of glycoprotein gD in the
adhesion of pseudorabies virus infected cells and subsequent
cell-associated virus spread. Arch Virol. 1995;140:1855–62.
81. Kopp M, Klupp BG, Granzow H, Fuchs W, Mettenleiter TC. Identification and
characterization of the pseudorabies virus tegument proteins UL46 and
UL47: role for UL47 in virion morphogenesis in the cytoplasm. J Virol.
2002;76:8820–33.
82. Klupp BG, Granzow H, Karger A, Mettenleiter TC. Identification, subviral
localization, and functional characterization of the pseudorabies virus UL17
protein. J Virol. 2005;79:13442–53.
83. Furth JJ, Whitbeck JC, Lawrence WC, Bello LJ. Construction of a viable BHV1
mutant lacking most of the short unique region. Arch Virol.
1997;142:2373–87.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Hall et al. Virology Journal  (2015) 12:130 Page 12 of 12
